Seemingly, the most significant achievement to date is the identification of two chemical inhibitors which interfere with STAT3 binding by Hsp110, thereby reducing the cancer cell proliferation rate and inhibiting tumor growth [195]. Here, HSPH1 is linked to neoplasm.